Effects of Training Given to Cope With Premenstrual Syndrome and Mandala Activity on Premenstrual Symptoms
Launched by ESKISEHIR OSMANGAZI UNIVERSITY · Dec 18, 2023
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how two different activities—Mandala drawing and education on coping with premenstrual syndrome (PMS)—can help reduce the symptoms of PMS in young women. Researchers want to find out if these activities can help manage common PMS issues like mood swings, cramps, and irritability. The trial involves three groups: one group will do Mandala drawing, another will receive education about coping with PMS, and the third group will not receive any specific intervention.
To participate, you need to be a female student aged 18 to 25 who has regular menstrual cycles and experiences significant PMS symptoms. You should not be using any PMS medications or contraceptives, and there are some health requirements to ensure you can safely take part. If you join the trial, you can expect to learn some new coping strategies and engage in creative activities, all aimed at helping you feel better during your menstrual cycle. This is a great opportunity to contribute to research that could help many others with PMS in the future!
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Age between 18-25 years
- • Female students enrolled in the 1st and 2nd years of the Faculty of Health Sciences PMSÖ score of 110 and above
- • Regular menstruation in the last six months (between 21-35 days)
- • Not using any medication or non-medication methods to cope with PMS symptoms
- • Not using contraceptive pills
- • Absence of any gynecological diseases (abnormal uterine bleeding, fibroids, ovarian cysts, etc.)
- • No diagnosis of psychiatric illness
- • Not using any psychiatric medication such as antidepressants
- • Absence of any condition that may hinder Mandala drawing
- • No previous experience with Mandala education
- • Willingness to participate in the study
- • Proficiency in speaking and understanding Turkish
- • Exclusion Criteria: Students who do not meet the criteria mentioned above and are not willing to participate in the study will be excluded.
- • -
About Eskisehir Osmangazi University
Eskisehir Osmangazi University is a distinguished academic institution dedicated to advancing medical research and education. With a commitment to enhancing healthcare outcomes, the university actively sponsors clinical trials that explore innovative therapeutic approaches and contribute to the scientific community. Leveraging its state-of-the-art facilities and a team of experienced researchers, Eskisehir Osmangazi University fosters collaboration across disciplines to address pressing health challenges and improve patient care. Through its rigorous research initiatives, the university aims to translate findings into practical applications that benefit both local and global populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bilecik, , Turkey
Bilecik, Merkez, Turkey
Patients applied
Trial Officials
Merve SEZER YILDIZ, Ph.D. Student
Principal Investigator
BİLECİK ŞEYH EDEBALİ UNİVERSITY
Özlem ÇAĞAN, Assist. Professor
Study Director
ESKİŞEHİR OSMANGAZİ UNİVERSITY
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported